Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

JANUARY 19, 2022

(ASX: LGP) (“LGP”), a vertically integrated cannabis manufacturer, that AMP has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany , including exclusive distributor of LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils. ” Ms. .”

Extraction 52

Extraction Oil Research and Development Medicine 52

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels. Westlund, Department of Anesthesiology. percent on a dry weight basis.”.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

NOVEMBER 3, 2021

This is a strategic opportunity for us to reach the widest audience of customers possible while being the first and, at the moment, the only company with a permit to market cannabis extracts for inhalation in Germany specifically and in Europe in general.

Extraction 52

Extraction Pharmaceutical Patients Treatment 52

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. Virginia has an “extraction-based” model; it’s not unique. 5 percent by dry weight means something entirely different than 5 percent in a liquid pharmaceutical measurement.

Marijuana 241

Marijuana Legalization Programs Oil 241

Cannabis Law Report

JUNE 2, 2021

and has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.” Pharmaceutical Grade CBD Oil. Idaho Code § 37-2701 et seq. A Schedule I substance is one that “has high potential for abuse. Idaho Code § 37-2704. See AG Report at 133.

Law 103

Law Marijuana Oil Pharmaceutical 103

Veriheal

AUGUST 9, 2023

This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.

CBD 96

CBD Cannabinoids THC Extraction 96

The Cannigma

MARCH 7, 2022

Therefore, it makes sense that CBN is most commonly found in aged or improperly stored cannabis, and hardly ever present in fresh flower or low-temp extractions. Preclinical studies by InMed Pharmaceuticals showed that CBN not only reduced markers of inflammation and pain, but also increased keratin.

THC 139

THC Sleep Clinical Trials Cannabinoids 139

Miss Marijuana

NOVEMBER 4, 2020

As a company that takes pride in their safety level, Matter produces quality, effective, and consistent products that can provide therapeutic relief to those suffering from chronic medical conditions. The brand’s growers are pharmaceutical experts who think of the user’s best needs every step of the way. Abx – AbsoluteXrracts.

Strains 98

Strains Concentrates Extraction Pharmaceutical 98

The Cannigma

JUNE 15, 2021

Another factor that increased CBD’s popularity was the FDA approval of an antiepileptic cannabis-based drug named Epidiolex — a highly concentrated CBD extraction mixed with sesame oil and some flavoring. But the main issue with hemp derived products and their safety is less about the CBD and more about everything else in them.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 24, 2021

With the filed patent on entactogenic compounds, the company would be able to further develop treatments that precisely match the needs of medical practice, by reducing harm and improving the safety profile when compared to traditional MDMA. The new patent filings are anticipated to populate the pipeline beyond MYCO-004.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Canna Care Docs

OCTOBER 3, 2023

However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill. Depending on the type of terminal illness diagnosed by the doctor, there are numerous pharmaceutical and conventional medications provided for patients to treat the symptoms that come with a terminal illness.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

The Cannigma

MARCH 17, 2021

Some women who chose to use cannabis for postpartum depression say they did so because standard prescription treatments did not help and the side effects from pharmaceutical treatments were intolerable. Of course, if a new mother is not breastfeeding, this is a moot point. Shutterstock). Thus, only “clean” products should be used.

Research and Development 141

Research and Development Treatment Sleep Cannabis 141

Cannabis Law Report

JULY 12, 2021

Pure Extracts Inc. Algernon Pharmaceuticals Inc. CSE: MSET) revealed additional preclinical data showing strong efficacy and improved safety in a head-to-head comparison with psilocybin. Weekly Performance: $133.19 (-1.61%). Powered by. CFN Enterprises Inc. OTCQB: CNFN). Top Gainers. CSE: PULL). 0.385 +0.155 (67.39%).

Treatment 66

Treatment Decriminalization Pharmaceutical Data 66

Cannabis Law Report

DECEMBER 2, 2021

Products that are listed as having been verified as meeting the minimum quality standards are unapproved medicines – there has been no assessment of their safety or efficacy. MW Pharma Limited t/a NUBU Pharmaceuticals. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. Date Verified.

Medicine 52

Medicine Pharmaceutical Sativa THC 52

Otherside Farms

MAY 1, 2023

As the cannabis industry continues to grow, the need for high-quality extraction methods becomes more important than ever. So, if you’re looking to take your cannabis business to the next level, it’s time to hop on the CO2 extraction train. What exactly is CO2 Extraction?

Extraction 52

Extraction Oil Terpenes Cannabinoids 52

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. The push for CBD is not surprising, whether it’s sold as a pharmaceutical drug or as a “dietary supplement” similar to gingko biloba or St.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

JUNE 20, 2019

Specifically, airmen are concerned about the safety of cannabidiol (CBD) oil use and how such use impacts an airman’s medical certificate. Be aware that federal law — not state law — governs FAA medical and pilot certification. One such compound being widely marketed is CBD oil.

THC 74

THC CBD Oil DEA 74

Cannabis Law Report

DECEMBER 19, 2021

Products that are listed as having been verified as meeting the minimum quality standards are unapproved medicines – there has been no assessment of their safety or efficacy. MW Pharma Limited t/a NUBU Pharmaceuticals. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. Date Verified.

Medicine 52

Medicine Pharmaceutical THC Sativa 52

Project CBD

FEBRUARY 28, 2023

1 SPINS’ CBD category typically includes sales of products that contain hemp-based CBD extracts, including CBD oils, gummies, and capsules. (THC is the primary psychoactive compound in cannabis.) Cannabis sativa with more than 0.3% THC is considered “marijuana” or “cannabis.”

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 3, 2022

TASE: PNAX), a global pharma company that develops, manufactures and markets progressive cannabis-based products in pharmaceutical quality, announced today that it has received official approval for the EU-GMP standard for its production facility in Malta from EU Health Authority. SOURCE Panaxia Pharmaceutical Industries.

Pharmaceutical 52

Pharmaceutical Chronic Pain Extraction Epilepsy 52

Cannabis Law Report

SEPTEMBER 3, 2019

Construction of New Melbourne-area Extraction Facility on Schedule. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. (TSX:

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

FEBRUARY 2, 2022

Lab Society is a Leader in Distillation and Solvent Separation Solutions for the Cannabis Extraction Industry with $10 Million in Annual Revenue. Acquisition Further Solidifies Agrify as the Largest and Most Comprehensive Provider of High- Quality Extraction Solutions for the Cannabis and Hemp Industry Globally. BILLERICA, Mass.,

Extraction 52

Extraction Pharmaceutical Hemp Cultivation 52

Cannabis Law Report

MARCH 30, 2020

. (“Charlotte’s Web” or the “Company”), the world’s most trusted hemp extract and market leader in hemp-derived cannabidiol (“CBD”) wellness products , is pleased to announce that David Panter has joined the Company as Chief Operating Officer, effective March 30, 2020.

Supply Chain 59

Supply Chain Extraction Hemp Pets 59

Cannabis Law Report

OCTOBER 22, 2021

Lenabasum: Corbus Pharmaceuticals Corbus Pharmaceuticals is developing Lenabasum, and currently it is in phase III stage of development for the treatment of multiple indications, such as dermatomyositis, systemic scleroderma, cystic fibrosis, systemic lupus erythematosus etc. Corbus Pharmaceuticals. TO Pharmaceuticals.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Cannabis Law Report

NOVEMBER 27, 2019

It is only through reasonable regulation that quality and safety be delivered to the public, and Folium believes the FDA must act against producers and distributors of CBD who do not meet quality and safety standards. CBD Isolate is a drug ingredient, as evidenced by GW Pharmaceutical’s Epidiolex product.

Hemp 45

Hemp Cannabinoids Supply Chain Pharmaceutical 45

Cannabis Law Report

OCTOBER 6, 2021

Some of the work would include researching extraction of pharmaceutically relevant compounds from psychedelic mushrooms and turning those extracts into medical products. Delic Labs is a federally authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development.

Research and Development 52

Research and Development Extraction Treatment Safety 52

SpeedWeed

AUGUST 1, 2021

announced on July 30 that the company’s CW Labs science division and Colorado State University’s (CSU) College of Agricultural Sciences have completed the first of three collaborative metabolomic hemp studies to decode the complex chemical profile of full spectrum hemp extracts—made from the company’s patented hemp cultivars. .

Hemp 52

Hemp Extraction Agriculture Strains 52

Canna Law Blog

JANUARY 26, 2019

Chemical extraction methods can isolate these active compounds while removing water, fiber, and other unwanted material. “Full spectrum” extracts are the extracts that contain a wide array of compounds found in the hemp plant, including cannabinoids and terpenes. . Epidiolex is an example of a CBD isolate.

Hemp 73

Hemp CBD Food Extraction 73

CannaMD

MAY 14, 2020

Safety of production and packaging. Based on this research, the authors concluded that: [C]o-administration of dietary lipids or pharmaceutical lipid excipients has the potential to substantially increase the exposure to orally administered cannabis and cannabis-based medicines. Risks of over-consumption and accidental ingestion.

Edibles 105

Edibles Marijuana THC Vaping 105

The Blunt Truth

DECEMBER 4, 2019

Specifically, the bill proposes to make it unlawful for an employer to take adverse action against an applicant or employee who is a qualified patient using medical marijuana consistent with state law, unless the position held or sought is one involving “safety-sensitive job duties.” The dispensing of pharmaceuticals.

Marijuana 65

Marijuana Safety Packaging State Laws 65

Cannabis Law Report

JULY 27, 2022

If a government chooses this lane, they have a responsibility to ensure safety, quality, and consistency. The next lane is pharmaceutical. This lane makes cannabis available to companies to develop pharmaceutical-grade medicines. This is marijuana in its natural state, not to be confused with medical marijuana.

Supply Chain 52

Supply Chain Pharmaceutical Policy Food 52

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. MMJ is confident that their pharmaceutical drugs will bring much needed relief to patients suffering from the debilitating effects of Multiple Sclerosis and Huntington’s Disease.

DEA 51

DEA Clinical Trials THC Research and Development 51

WeedAdvisor

JUNE 19, 2019

Colombian producer Green Equity was first on the list: “By purchasing Green Equity, which holds Colombian business licenses for marijuana cultivation, manufacturing, extraction, exportation and research, Medicine Man Technologies will further its plans to create a global footprint as support for marijuana legalization grows.”.

Medicine 53

Medicine Extraction Pharmaceutical Compliance 53

Cannabis Law Report

FEBRUARY 18, 2020

I think anybody selling whole CBD extract products can just continue. The crucial part is that if they really had any genuine concern about safety, how could they possible give people only a year to submit an application?”. They obviously feel under pressure to do something. A UK cannabis regulation authority is the solution.

CBD 59

CBD Food Medicine Pharmaceutical 59

MMJ Recs

JULY 11, 2024

Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Cannabis Law Report

JUNE 19, 2019

Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model. The involvement of numerous pathways associated with lipid and xenobiotic metabolism raises serious concerns about potential drug interactions as well as the safety of CBD. Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model.

CBD 40

CBD Research and Development Extraction Pharmaceutical 40